Ronald E. Laliberte

1.2k total citations
20 papers, 941 citations indexed

About

Ronald E. Laliberte is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ronald E. Laliberte has authored 20 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Ronald E. Laliberte's work include Reproductive System and Pregnancy (3 papers), Vitamin K Research Studies (3 papers) and Immune Response and Inflammation (3 papers). Ronald E. Laliberte is often cited by papers focused on Reproductive System and Pregnancy (3 papers), Vitamin K Research Studies (3 papers) and Immune Response and Inflammation (3 papers). Ronald E. Laliberte collaborates with scholars based in United States, Canada and Switzerland. Ronald E. Laliberte's co-authors include Christopher A. Gabel, David G. Perregaux, James F. Eggler, Mark A. Dombroski, LP Boulet, Jean Y. Dubé, M Boutet, Michel Laviolette, Jamila Chakir and Lise R. Hoth and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Ronald E. Laliberte

20 papers receiving 913 citations

Peers

Ronald E. Laliberte
A J Perlman United States
Paisit Paueksakon United States
Maribel Mirabet Spain
C. Koehl France
Lihua Ying United States
Cemil Korcan Ayata Germany
Naziba Islam United States
Gerald S. Braun Germany
Gregory Bell United States
Pedro Chacón Spain
A J Perlman United States
Ronald E. Laliberte
Citations per year, relative to Ronald E. Laliberte Ronald E. Laliberte (= 1×) peers A J Perlman

Countries citing papers authored by Ronald E. Laliberte

Since Specialization
Citations

This map shows the geographic impact of Ronald E. Laliberte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Laliberte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Laliberte more than expected).

Fields of papers citing papers by Ronald E. Laliberte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Laliberte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Laliberte. The network helps show where Ronald E. Laliberte may publish in the future.

Co-authorship network of co-authors of Ronald E. Laliberte

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Laliberte. A scholar is included among the top collaborators of Ronald E. Laliberte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Laliberte. Ronald E. Laliberte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voi, Maurizio, John Nemunaitis, Jessica R. Bauman, et al.. (2012). 590 Final Results of a Phase Ib Study of CUDC-101, a Multitargeted Inhibitor of EGFR, HER2, and HDAC, in Patients with Advanced Head and Neck, Gastric, Breast, Liver, and Non-small Cell Lung Cancer. European Journal of Cancer. 48. 181–181. 5 indexed citations
2.
Perotti, Antonella, Lucia Viganò, Elisa Gallerani, et al.. (2006). Phase Ib pharmacokinetic (PK) and pharmacodynamic (PD) study to define the optimal dose for combining the mTOR inhibitor AP23573 with capecitabine (CAPE). Journal of Clinical Oncology. 24(18_suppl). 3065–3065. 8 indexed citations
3.
Feldman, Eric J., Francis J. Giles, Karen Yee, et al.. (2005). A phase 2 clinical trial of AP23573, an mTOR inhibitor, in patients with relapsed or refractory hematologic malignancies. Journal of Clinical Oncology. 23(16_suppl). 6631–6631. 19 indexed citations
4.
Laliberte, Ronald E., David G. Perregaux, Lise R. Hoth, et al.. (2003). Glutathione S-Transferase Omega 1-1 Is a Target of Cytokine Release Inhibitory Drugs and May Be Responsible for Their Effect on Interleukin-1औ Posttranslational Processing. Journal of Biological Chemistry. 278(19). 16567–16578. 169 indexed citations
5.
Perregaux, David G., Ronald E. Laliberte, Natalie A. Hawryluk, et al.. (2001). Identification and Characterization of a Novel Class of Interleukin-1 Post-Translational Processing Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 299(1). 187–197. 168 indexed citations
6.
Laliberte, Ronald E., James F. Eggler, & Christopher A. Gabel. (1999). ATP Treatment of Human Monocytes Promotes Caspase-1 Maturation and Externalization. Journal of Biological Chemistry. 274(52). 36944–36951. 115 indexed citations
7.
Laliberte, Ronald E., et al.. (1997). Human monocyte ATP-induced IL-1β posttranslational processing is a dynamic process dependent on in vitro growth conditions. Journal of Leukocyte Biology. 62(2). 227–239. 26 indexed citations
8.
Perregaux, David G., Ronald E. Laliberte, & Christopher A. Gabel. (1996). Human Monocyte Interleukin-1β Posttranslational Processing. Journal of Biological Chemistry. 271(47). 29830–29838. 96 indexed citations
9.
Chakir, Jamila, Michel Laviolette, M Boutet, et al.. (1996). Lower airways remodeling in nonasthmatic subjects with allergic rhinitis.. PubMed. 75(5). 735–44. 115 indexed citations
10.
Laliberte, Ronald E., et al.. (1995). Inhibition of Cytokine Activation Processes In Vitro by Tenidap, a Novel Anti-Inflammatory Agent. Cytokine. 7(2). 196–208. 13 indexed citations
11.
Laliberte, Ronald E., et al.. (1994). Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.. The Journal of Immunology. 153(5). 2168–2179. 63 indexed citations
12.
Carty, Thomas J. & Ronald E. Laliberte. (1989). The biochemistry and pharmacology of interleukins-1 and -6. Inflammation Research. 26(3-4). 391–393. 7 indexed citations
13.
Schwartz, Steven O., et al.. (1987). Effectiveness of mandibular infiltration in children using the local anesthetic Ultracaine (articaine hydrochloride).. PubMed. 53(1). 29–31. 31 indexed citations
14.
Hélie, Pierre, et al.. (1984). [Ultracaine in conventional operative dentistry].. PubMed. 50(9). 703–8. 18 indexed citations
15.
Laliberte, Ronald E., et al.. (1982). Nomifensine in the treatment of depressed geriatric patients.. PubMed. 43(7). 287–9. 11 indexed citations
16.
Laliberte, Ronald E., Sasanka Chakrabarti, & J. Brodeur. (1977). The influence of fasting on the disposition of warfarin in rats.. Journal of Pharmacology and Experimental Therapeutics. 200(1). 44–51. 12 indexed citations
17.
Tolis, G., Ronald E. Laliberte, H. Guyda, & Frederick Naftolin. (1977). Ineffectiveness of Pyridoxine (B6) to Alter Secretion of Growth Hormone and Prolactin and Absence of Therapeutic Effects on Galactorrhea-Amenorrhea Syndromes. The Journal of Clinical Endocrinology & Metabolism. 44(6). 1197–1199. 16 indexed citations
18.
Laliberte, Ronald E., et al.. (1976). Inhibition of vitamin K epoxidase by two non-coumarin anticoagulants. Biochemical Pharmacology. 25(9). 1063–1066. 21 indexed citations
19.
Laliberte, Ronald E., Sasanka Chakrabarti, & J. Brodeur. (1976). The influence of fasting and stress on the response of rats to warfarin.. Journal of Pharmacology and Experimental Therapeutics. 196(1). 194–203. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A J Perlman Breakdown of academic impact, for papers by Paisit Paueksakon Breakdown of academic impact, for papers by Maribel Mirabet Breakdown of academic impact, for papers by C. Koehl Breakdown of academic impact, for papers by Lihua Ying Breakdown of academic impact, for papers by Cemil Korcan Ayata Breakdown of academic impact, for papers by Naziba Islam Breakdown of academic impact, for papers by Gerald S. Braun Breakdown of academic impact, for papers by Gregory Bell Breakdown of academic impact, for papers by Pedro Chacón
Rankless by CCL
2026